{"id":550611,"date":"2026-03-15T12:30:00","date_gmt":"2026-03-15T11:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=550611"},"modified":"2026-03-15T12:55:30","modified_gmt":"2026-03-15T11:55:30","slug":"biologicos-estabelecidos-e-novos-o-panorama-terapeutico-esta-a-mudar","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/biologicos-estabelecidos-e-novos-o-panorama-terapeutico-esta-a-mudar\/","title":{"rendered":"Biol\u00f3gicos estabelecidos e novos &#8211; o panorama terap\u00eautico est\u00e1 a mudar"},"content":{"rendered":"\n<p><strong>Clinicamente, a dermatite at\u00f3pica (DA) manifesta-se atrav\u00e9s de um quadro polim\u00f3rfico de efloresc\u00eancias, com prurido e xerose em primeiro plano. Para al\u00e9m das terapias com anticorpos dupilumab, tralokinumab e lebrikizumab, que t\u00eam como alvo a via de sinaliza\u00e7\u00e3o IL-4\/IL-13, est\u00e1 agora dispon\u00edvel para o tratamento da DA um quarto medicamento biol\u00f3gico, o nemolizumab. Este \u00faltimo tem como alvo o recetor IL-31, que medeia o prurido n\u00e3o-histamin\u00e9rgico. H\u00e1 tamb\u00e9m resultados promissores de estudos cl\u00ednicos com anticorpos anti-OX40(L).   <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fbiologicos-estabelecidos-e-novos-o-panorama-terapeutico-esta-a-mudar%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Clinicamente, a dermatite at\u00f3pica (DA) manifesta-se atrav\u00e9s de um quadro polim\u00f3rfico de efloresc\u00eancias, com prurido e xerose em primeiro plano. Para al\u00e9m das terapias com anticorpos dupilumab, tralokinumab e lebrikizumab,&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fbiologicos-estabelecidos-e-novos-o-panorama-terapeutico-esta-a-mudar%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":550612,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Dermatite at\u00f3pica moderada a grave  ","footnotes":""},"category":[11344,11356,11521,11524,11551],"tags":[65601,88959,12217,12487,12492,13525,16238,82408,82406,85928,65865,88960,59201,13302,88961],"powerkit_post_featured":[],"class_list":["post-550611","post","type-post","status-publish","format-standard","has-post-thumbnail","category-alergologia-e-imunologia-clinica","category-dermatologia-e-venereologia-pt-pt","category-estudos","category-formacao-continua","category-rx-pt","tag-adtralza-pt-pt","tag-anticorpo-anti-ox40l","tag-biologicos","tag-comichao","tag-dermatite-atopica","tag-dupilumab-pt-pt","tag-dupixent-pt-pt","tag-ebglyss-pt-pt","tag-lebrikizumab-pt-pt","tag-nemluvio","tag-nemolizumab-pt-pt","tag-recetor-de-il-31","tag-terapia-de-anticorpos","tag-tralokinumab-pt-pt","tag-via-de-sinalizacao-il-4-il-13","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-13 12:51:12","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":550608,"slug":"biologicos-establecidos-y-novedosos-el-panorama-terapeutico-esta-en-constante-cambio","post_title":"Biol\u00f3gicos establecidos y novedosos: el panorama terap\u00e9utico est\u00e1 en constante cambio","href":"https:\/\/medizinonline.com\/es\/biologicos-establecidos-y-novedosos-el-panorama-terapeutico-esta-en-constante-cambio\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/550611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=550611"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/550611\/revisions"}],"predecessor-version":[{"id":550613,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/550611\/revisions\/550613"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/550612"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=550611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=550611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=550611"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=550611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}